With a 25-lakh-square-foot pharmaceutical park in Tyumen, Russia, SRK Pharmaceuticals develops and contract-manufactures drug products and nicotine replacement therapies for international markets. Founded 26 years ago, the company operates 14 manufacturing sites, supported by a global R&D center in Singapore and capabilities spanning oral, injectable, liquid and NRT formulations. Its facilities are described as GMP-compliant and certified or licensed under ISO 13485, FDA, TGA and WHO-related requirements.
Good Manufacturing Practice (GMP)
ISO 13485
Australian Register of Therapeutic Goods (ARTG)
Registration
Therapeutic Goods Administration (TGA)
Compliance program
USFDA
Compliance program
APVMA
Compliance program
WHO-GMP
Compliance program
REACH
Compliance program
PMTA
Compliance program
CE Compliance
WHO-GDP
Compliance program
GMP
Quality certification
TGA
Quality certification
FDA
Quality certification
CE
Quality certification